TCT-39 Long-term Clinical Outcomes in Real-World Patients with Acute Myocardial Infarction Receiving XIENCE V® Everolimus-Eluting Stents: Four-Year Results from the XIENCE V USA Study

Autor:	Sherry Cao, Vivian W. Mao, Krishnankutty Sudhir, David R. Rutledge
Rok vydání:	2014
Předmět:	education.field_of_study medicine.medical_specialty business.industry Everolimus eluting stent Population medicine.disease Internal medicine Cardiology medicine Myocardial infarction cardiovascular diseases education business Cardiology and Cardiovascular Medicine
Zdroj:	Journal of the American College of Cardiology. 64(11)
ISSN:	0735-1097
DOI:	10.1016/j.jacc.2014.07.063
Popis:	XIENCE V USA is a prospective, multicenter, single-arm, FDA condition- of-approval study to evaluate the safety and effectiveness of the XIENCE V® Everolimus Eluting Stent (XIENCE V, Abbott Vascular, Santa Clara, CA) in a real-world, all-comer population. Clinical outcomes at 1 year in AMI patients
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f985e8027a8d287cf98dabfd23c9d62f Zobrazit plný text záznamu